Melatonin as an adjuvant: reshaping glaucoma treatment strategies.
作者信息
Ali Moonis, Reutrakul Sirimon, Vajaranant Thasarat Sutabutr
机构信息
Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
出版信息
Eye (Lond). 2024 Dec;38(18):3409-3411. doi: 10.1038/s41433-024-03358-w. Epub 2024 Sep 26.
Abstract
摘要
相似文献
1
Melatonin as an adjuvant: reshaping glaucoma treatment strategies.
Eye (Lond). 2024 Dec;38(18):3409-3411. doi: 10.1038/s41433-024-03358-w. Epub 2024 Sep 26.
2
Safety and efficacy of melatonin as an adjuvant therapy in COVID-19 patients: Systematic review and meta-analysis.
Adv Med Sci. 2023 Sep;68(2):341-352. doi: 10.1016/j.advms.2023.09.007. Epub 2023 Sep 22.
3
Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT.
Health Technol Assess. 2025 Jul;29(29):1-25. doi: 10.3310/CWKF1987.
4
Widespread pain syndrome in long COVID-19: melatonin as an adjuvant treatment.
Front Pain Res (Lausanne). 2025 Jun 4;6:1609095. doi: 10.3389/fpain.2025.1609095. eCollection 2025.
5
Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis.
Complement Ther Med. 2018 Aug;39:131-136. doi: 10.1016/j.ctim.2018.06.002. Epub 2018 Jun 11.
6
The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.
Cancer Chemother Pharmacol. 2012 May;69(5):1213-20. doi: 10.1007/s00280-012-1828-8. Epub 2012 Jan 24.
7
.
Int Ophthalmol. 2025 Jun 27;45(1):266. doi: 10.1007/s10792-025-03602-6.
8
The Utility of a Smartphone-Based Retinal Imaging Device as a Screening Tool in an Outpatient Clinic Setting: Protocol for an Observational Study.
JMIR Res Protoc. 2025 Mar 25;14:e52650. doi: 10.2196/52650.
9
Melatonin in the eye: implications for glaucoma.
Exp Eye Res. 2007 Jun;84(6):1021-30. doi: 10.1016/j.exer.2006.10.018. Epub 2006 Dec 14.
10
Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues.
Curr Med Chem. 2012;19(21):3508-22. doi: 10.2174/092986712801323234.
本文引用的文献
1
Melatonin and Risk of Age-Related Macular Degeneration.
JAMA Ophthalmol. 2024 Jul 1;142(7):648-654. doi: 10.1001/jamaophthalmol.2024.1822.
2
Post-Illumination Pupil Response and Sleep Quality in Patients With Glaucoma: The LIGHT Study.
Invest Ophthalmol Vis Sci. 2023 Sep 1;64(12):34. doi: 10.1167/iovs.64.12.34.
3
Intrinsically photosensitive retinal ganglion cells in glaucoma.
Front Cell Neurosci. 2022 Sep 23;16:992747. doi: 10.3389/fncel.2022.992747. eCollection 2022.
4
Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma.
J Pineal Res. 2021 May;70(4):e12730. doi: 10.1111/jpi.12730. Epub 2021 Mar 28.
5
Glaucoma and neuroinflammation: An overview.
Surv Ophthalmol. 2021 Sep-Oct;66(5):693-713. doi: 10.1016/j.survophthal.2021.02.003. Epub 2021 Feb 11.
6
Decreased melatonin secretion in patients with glaucoma: Quantitative association with glaucoma severity in the LIGHT study.
J Pineal Res. 2020 Sep;69(2):e12662. doi: 10.1111/jpi.12662. Epub 2020 May 27.
7
Melatonin and the control of intraocular pressure.
Prog Retin Eye Res. 2020 Mar;75:100798. doi: 10.1016/j.preteyeres.2019.100798. Epub 2019 Sep 25.
8
Melatonin Levels in Patients With Primary Open-angle Glaucoma With High or Low Intraocular Pressure.
J Glaucoma. 2019 Feb;28(2):154-160. doi: 10.1097/IJG.0000000000001130.
9
Circadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and Countermeasures.
Endocr Rev. 2016 Dec;37(6):584-608. doi: 10.1210/er.2016-1083. Epub 2016 Oct 20.
10
Relationship Between Nocturnal Intraocular Pressure Variations and Sleep Macrostructure.
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6899-905. doi: 10.1167/iovs.15-17456.
Zotero 插件